Literature DB >> 7730612

IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones.

J Louahed1, A Kermouni, J Van Snick, J C Renauld.   

Abstract

Interleukin 9 (IL-9) is a TH2 cytokine that has been shown to promote the antigen-independent growth of some mouse T helper clones. To characterize the specificity of IL-9-mediated T cell activation, we used a murine T cell clone that could grow with either IL-9 or IL-2. After differential hybridization of a cDNA library, we isolated three genes that were expressed preferentially in the presence of IL-9. Two of them correspond respectively to granzyme A and granzyme B, two proteases expressed by activated T cells. By Northern blot hybridization and functional assays, we found that IL-9 induced the expression of granzyme B in several T cell clones as well as in mast cell lines. In addition, other proteases such as the mouse mast cell proteases were also found to be expressed by IL-9-activated T cell clones. The third IL-9-induced cDNA corresponds to the alpha-chain of the high-affinity receptor for IgE. Several T cell clones expressed this IgE receptor mRNA and were able to bind IgE with high affinity. Taken together, our results indicate that IL-9 induces a mast cell-like phenotype in T cell clones.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  The effect of PDIA3 gene knockout on the mucosal immune function in IBS rats.

Authors:  Zhao-Meng Zhuang; Xiao-Teng Wang; Lu Zhang; Li-Yuan Tao; Bin Lv
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Authors:  Lorraine Springuel; Elisabeth Losdyck; Pascale Saussoy; Béatrice Turcq; François-Xavier Mahon; Laurent Knoops; Jean-Christophe Renauld
Journal:  Cell Mol Life Sci       Date:  2016-07-19       Impact factor: 9.261

4.  IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma.

Authors:  M R Finiasz; M C Franco; S de la Barrera; L Rutitzky; G Pizzariello; M del Carmen Sasiain; J-C Renauld; J Van Snick; S Fink
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 5.  Immunobiology of critical pediatric asthma.

Authors:  Stacey Galowitz; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 6.  New insights into the role of cytokines in asthma.

Authors:  J C Renauld
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

7.  A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

Authors:  D F Dukers; R L ten Berge; J J Oudejans; K Pulford; D Hayes; J F Miseré; G J Ossenkoppele; L H Jaspars; R Willemze; C J Meijer
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

8.  TH9 cells are required for tissue mast cell accumulation during allergic inflammation.

Authors:  Sarita Sehra; Weiguo Yao; Evelyn T Nguyen; Nicole L Glosson-Byers; Nahid Akhtar; Baohua Zhou; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-03-05       Impact factor: 10.793

9.  Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi.

Authors:  Frederik Van Meulder; Stefanie Van Coppernolle; Jimmy Borloo; Manuela Rinaldi; Robert W Li; Koen Chiers; Wim Van den Broeck; Jozef Vercruysse; Edwin Claerebout; Peter Geldhof
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Authors:  S B Early; P Huyett; K Brown-Steinke; L Borish; J W Steinke
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.